SciELO - Scientific Electronic Library Online

 
vol.24 issue1Prevalencia serológica de anticuerpos al virus de la Hepatitis C en personal de salud en el PerúA new technique of laparoscopic surgery for rectal disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de Gastroenterología del Perú

Print version ISSN 1022-5129

Abstract

ARBAYZA-AVALOS, Yessenia Katherin; DIAZ-PLASENCIA, Juan Alberto; SEGURA-PLASENCIA, Niler Manuel  and  YAN-QUIROZ, Edgar Fermín. Significancia pronóstica del estadío clínico TNM en la sobrevida quinquenal en carcinoma primario de vesícula biliar. Rev. gastroenterol. Perú [online]. 2004, vol.24, n.1, pp.21-27. ISSN 1022-5129.

PURPOSE. To determine the prognosis significance of the TNM clinic stage and the five-year survival rate of patients with primary carcinoma of the gallbladder. MATERIAL AND METHODS: A descriptive, longitudinal, observational study with a single-box empirical design that evaluated 71 patients with gallbladder cancer who had surgical resection of the neoplasia in the Belén Hospital in Trujillo, Peru between 1966 and 2000. RESULTS: The mean age of the total series was 61.6±12.04 years (ranging from 33 to 88 years). Most of the patients belonged to the age group of 60 years or older (56.3%). Ten patients were males (14.1%) and 61 were females (85.9%), with a M:F ratio of 1:6.1. In the univariate analysis using the log-rank test, the following variables were significantly related to a five-year survival time: primary tumor (p=0.0001), regional ganglionic condition (p=0.0038), clinic stage (p=0.00001). The actuarial survival rate of all the series at 12, 36, and 60 months was 30%, 14.1%, and 11.3%, respectively. CONCLUSIONS: The prognosis factors significantly related to five-year survival were: primary tumor (p=0.0001), regional ganglionic condition (p=0.0038) and clinic stage (p=0.00001). The actuarial survival rate of all the series at 12, 36, and 60 months was 30%, 14.1%, and 11.3%, respectively.

Keywords : Gallbladder carcinoma; TNM; Survival.

        · abstract in Spanish     · text in Spanish